Is this time different? "It better be," warns BofA strategist Michael Hartnett. By one metric, stock valuations are beyond ...

US stocks were mixed on Friday as Wall Street tempered its rate-cut hopes amid economic data this week that showed ...

There's record amounts of cash on the sidelines in money market funds, but putting cash to work as the market swoons can be ...

Berkshire Hathaway is deploying its $344B cash pile into undervalued stocks like UnitedHealth, while trimming Apple and BAC.

On the profitability front, Cava's adjusted earnings before interest, taxes, depreciation, and amortization ( EBITDA) climbed ...

Eli Lilly's obesity drugs delivered 38% revenue growth in the second quarter; but its oral GLP-1 candidate fell short, ...

Afya's Q2 2025 results were solid, but the stock faces headwinds from market saturation and regulatory changes in Brazil's ...

What’s especially troubling is the way the multiple reached its current heights. The main driver wasn’t what matters most: ...

The Indian stock market showed recovery after six weeks, led by pharma and auto stocks. Key drivers include PM Modi's GST ...

President Trump had urged CEO Lip-Bu Tan to step down over his past ties with China. But the narrative flipped last week ...

According to Anshul Jain, Head of Research at Lakshmishree, the recent sharp post-listing rally in NSDL limits its immediate ...

Most investors weren't swayed by its second-quarter report. After more than a year's worth of unrewarded growth, they should ...